Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors

doi:10.4252/wjsc.v12.i5.323

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9615)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

592

WORD

230

HTML

5775

Figures (1-1)

351

Tables (1-4)

624

Sum=7572

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

765

Download

1278

Sum=2043

May 26, 2020 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. May 26, 2020; 12(5): 323-338
Published online May 26, 2020. doi: 10.4252/wjsc.v12.i5.323

Open in New Tab Full Size Figure Download Figure

Figure 1 Possible effects of mesenchymal stem cells and neurotrophic factors for Alzheimer’s disease, Parkinson’s disease, Huntington's disease and amyotrophic lateral sclerosis. AD: Alzheimer’s disease; ALS: Amyotrophic lateral sclerosis; BDNF: Brain-derived neurotrophic factor; CN: Cholinergic neurons; DN: Dopamine neurons; GDNF: Glial cell line-derived neurotrophic factor; GABA-N: Striatal GABAergic medium-sized spiny neurons; HD: Huntington's disease; MN: Motor neurons; MSCs: Mesenchymal stem cells; NGF: Nerve growth factor; NTFs: Neurotrophic factors; PD: Parkinson’s disease.

Citation: Wang J, Hu WW, Jiang Z, Feng MJ. Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. World J Stem Cells 2020; 12(5): 323-338
URL: https://www.wjgnet.com/1948-0210/full/v12/i5/323.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i5.323